Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rongde Seaweed, officially known as Qingdao Rongde Seaweed Co., Ltd., is a Chinese enterprise specializing in the extraction and processing of seaweed-based chemicals. The company is a significant producer of sodium alginate, mannitol, and iodine, serving diverse industries including pharmaceuticals, food production, and textiles. In the life sciences sector, Rongde provides high-purity pharmaceutical excipients used for tablet binding, stabilization, and the manufacturing of medical wound dressings. The company operates from a major industrial base in Qingdao, Shandong, leveraging local marine resources to supply both domestic and international markets. Their manufacturing processes include large-scale extraction and purification technologies designed to meet various industrial and pharmaceutical grade requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rongde Seaweed.